Baltas Pharma OÜ

Active Registry code 12779856 OÜ Tallinn Registered 9 Jan 2015

Baltas Pharma OÜ is a OÜ based in Tallinn, registry code 12779856, status: active. Main activity: Wholesale of medical appliances and surgical and orthopaedic instruments and devices. According to EMTA, turnover for Q3 2026 was €8 240 with 1 employees.

Turnover

8 240 €

↑ 38.7% vs Q2 2026

State taxes

314 €

↓ 97.6% vs Q2 2026

Labour taxes

4 797 €

↑ 1.5% vs Q2 2026

Employees

±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Wholesale trade · EMTAK 46

Turnover · Q3 2026 8 240 €

above 22% of companies

industry median 60 065 € · companies in the industry: 6 941
Labour taxes per employee 4 797 €

above 84% of companies

industry median 2 104 € · companies in the industry: 4 194
Revenue · 2024 1.4 mn €

above 85% of companies

industry median 60 216 € · companies in the industry: 10 685
Net profit margin · 2024 1.6 %

above 43% of companies

industry median 2.9 % · companies in the industry: 7 870

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € thousand Q3 2026: 8 240 € · +38.7% vs Q2 2026 · industry median 60 065 € · above 22% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 4 797 € · +1.5% vs Q2 2026 · industry median 2 104 € · above 84% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 1 · +0.0% vs Q2 2026

State taxes, € Q3 2026: 314 € · −97.6% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	8 240	314	4 797	1
Q2 2026	5 941	13 069	4 727	1
Q1 2026	—	13 047	4 702	1
Q4 2025	284 475	4 605	4 722	1
Q3 2025	190 571	4 605	4 722	1
Q2 2025	2 985	4 605	4 722	1
Q1 2025	594 425	4 461	4 572	1
Q4 2024	327 440	4 272	4 381	1
Q3 2024	133 291	3 709	3 818	1
Q2 2024	52 824	2 583	2 691	1
Q1 2024	142 640	2 484	2 584	1
Q4 2023	209 762	2 406	2 498	1
Q3 2023	—	2 434	2 530	1
Q2 2023	18 809	2 434	2 530	1
Q1 2023	—	16	1 738	1
Q4 2022	—	1 054	994	—
Q3 2022	200	—	1 325	—
Q2 2022	9 527	471	471	—
Q1 2022	3 726	—	—	—

Labour taxes per employee per month

1 599 €

Turnover per employee in the quarter

8 240 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € thousand 2024: 1 435 004 € · −6.9% vs 2023 · industry median 60 216 € · above 85% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2024: 22 300 € · −79.3% vs 2023 · industry median 134 € · above 76% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 1.6 % · −5.4 pp vs the year before · industry median 2.9 % · above 43% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2024: 2 520 060 € · +17.2% vs 2023

Equity, € thousand 2024: 1 902 153 € · +1.2% vs 2023

Employees 2025: 2 · +0.0% vs 2024 · industry median 2 · above 45% of the industry

Company
Industry median

Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	—	—	—	—	—	2
2024	1 435 004	22 300	40 093	2 520 060	1 902 153	2
2023	1 541 859	107 729	28 566	2 150 065	1 879 853	2
2022	1 387 521	463 854	9 245	2 398 431	1 772 204	1
2021	1 149 738	182 987	0	1 409 489	1 308 350	0
2020	977 772	274 641	2 336	1 266 421	1 125 363	1
2019	1 594 622	288 605	34 616	1 170 089	850 722	2
2018	—	—	—	—	—	1
2017	—	—	—	—	—	0
2016	—	—	—	—	—	0
2015	—	—	—	—	—	0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Net profit margin

1.6 %

Net profit / revenue

Return on equity (ROE)

1.2 %

Net profit / equity

Return on assets (ROA)

0.9 %

Net profit / assets

Equity ratio

75.5 %

Equity / assets

Debt ratio

24.5 %

Liabilities / assets

Current ratio

4.08

Current assets / current liabilities

Revenue per employee

717 502 €

Revenue / average full-time employees

Labour cost per employee per month

1 671 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2024	1 Jan 2024 – 31 Dec 2024	27 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	16 Jul 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	30 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	14 Dec 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	28 Sep 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	1 Oct 2020	Company’s own	e-Äriregister

Board

Aleksandr Geibatov
Board member · since 16 Feb 2022
Lgk Oü
Person authorised to receive procedural documents · since 2 Jan 2018

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Aleksandr Geibatov
Natural person · 2 500 €

100%

Beneficial owners

Aleksandr Geibatov
Direct ownership · since 6 Dec 2022

Founders and other persons

Jaanus Vahl
Founder · 250 € · 29 Dec 2014
Siarhei Kulpeksha
Founder · 750 € · 29 Dec 2014
BARYS VINITSKI
Founder · 1 500 € · 2 Jun 2017

shared board members, owners or beneficial owners

Activities (EMTAK)

46462Wholesale of medical appliances and surgical and orthopaedic instruments and devices Main

Rulings 19

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 50000471 / M6 10 Jul 2024	Warning of deletion from the register: annual report not filed	13 Oct 2024	Deficiencies eliminated 17 Jul 2024	PDF
Ä 50000471 / 13 1 Sep 2023	Amendment entry		In force 1 Sep 2023	PDF
Ä 50000471 / 12 16 Feb 2022	Amendment entry		In force 16 Feb 2022	PDF
Ä 50000471 / 11 27 Feb 2020	Amendment entry		In force 27 Feb 2020	PDF
Ä 50000471 / M5 25 Feb 2020	Ruling to eliminate deficiencies	26 Mar 2020	Deficiencies eliminated 26 Feb 2020	PDF
Ä 50000471 / M4 19 Feb 2020	Ruling to eliminate deficiencies	20 Mar 2020	Deficiencies eliminated 26 Feb 2020	PDF
Ä 50000471 / 10 12 Mar 2019	Amendment entry		In force 12 Mar 2019	PDF
Ä 50000471 / 9 26 Feb 2018	Amendment entry		In force 26 Feb 2018	PDF
Ä 50000471 / 8 20 Jan 2018	Amendment entry		In force 20 Jan 2018	PDF
Ä 50000471 / 7 2 Jan 2018	Amendment entry		In force 2 Jan 2018	PDF
Ä 50000471 / 6 9 Dec 2017	Amendment entry		In force 9 Dec 2017	PDF
Ä 50000471 / 5 18 Sep 2017	Entry made by the register on its own initiative		In force 18 Sep 2017	PDF
Ä 50000471 / M3 16 Aug 2017	Procedural ruling		In force 16 Aug 2017	PDF
Ä 50000471 / 4 2 Jun 2017	Amendment entry		In force 2 Jun 2017	PDF
Ä 50000471 / 3 18 Apr 2017	Amendment entry		In force 18 Apr 2017	PDF
Ä 50000471 / 2 30 Jan 2017	Amendment entry		In force 30 Jan 2017	PDF
Ä 50000471 / M2 11 Jan 2017	Procedural ruling		In force 11 Jan 2017	PDF
Ä 50000471 / M1 19 Dec 2016	Procedural ruling		In force 19 Dec 2016	PDF
Ä 50000471 9 Jan 2015	First entry		In force 9 Jan 2015	PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data

Baltas Pharma OÜ

Position in the industry Wholesale trade · EMTAK 46

Taxes and turnover

Financials by year

Financial ratios for 2024

Annual reports

Board

Right of representation

Owners

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 19